EUVIMEDEUVIMED entdecken
Crossref

Hidradenitis suppurativa disease control associated with type of hormonal contraceptive use

Charles Y Huang iD, Saloni A Shah, Mikayla Cochrane, Annyella Douglas, Sherry Yang

Clinical and Experimental Dermatology · 2024

DOI: 10.1093/ced/llad385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Charles Y Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hidradenitis suppurativa (HS) is a painful chronic skin condition of apocrine gland regions. This retrospective cohort study aimed to assess the impact of hormonal contraception type on HS disease control in adult women. In total, 160 patients were included, with the majority identifying as Black or African American (73.1%). Multivariate logistic regression showed that oestrogen–progesterone users were 3.14 times more likely to experience stable or improved HS than progesterone-only users (adjusted odds ratio 3.14, 95% CI 1.18–8.35; P = 0.02). Further investigation is needed to elucidate the antiandrogenic mechanisms affecting HS symptom response to hormonal contraceptives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaAdultHumansFemaleRetrospective StudiesContraceptive AgentsProgesteroneApocrine Glands

Substanzen

Contraceptive AgentsProgesterone

Autor:innen und Institutionen

  • Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
  • Department of Dermatology and Cutaneous Biology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

ORCID-Profile: Charles Y Huang

Zitieren

APA

Huang, C. Y., Shah, S. A., Cochrane, M., Douglas, A., & Yang, S. (2024). Hidradenitis suppurativa disease control associated with type of hormonal contraceptive use. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad385

Vancouver

Huang CY, Shah SA, Cochrane M, Douglas A, Yang S. Hidradenitis suppurativa disease control associated with type of hormonal contraceptive use. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llad385

BibTeX
@article{Huang2024,
  author = {Huang, Charles Y and Shah, Saloni A and Cochrane, Mikayla and Douglas, Annyella and Yang, Sherry},
  title = {Hidradenitis suppurativa disease control associated with type of hormonal contraceptive use},
  journal = {Clinical and Experimental Dermatology},
  year = {2024},
  doi = {10.1093/ced/llad385}
}
Kostenlos starten →